For laboratory research use only. Not for human or veterinary use.

Same-day dispatch on orders before 4 PM ET · Support

Semax and Selank: Research Overview

Semax and Selank are synthetic heptapeptides developed by Russian research groups and registered in Russia as nasal drug products. Semax (MEHFPGP) is derived from the ACTH(4-10) fragment, and Selank (TKPRPGP) from tuftsin. Both end in Pro-Gly-Pro. Neither is FDA-approved in the United States.

Reference table

PropertySemaxSelank
SequenceMet-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
Parent peptideACTH(4-7) core of the ACTH(4-10) fragment, plus C-terminal Pro-Gly-Pro [4]Tuftsin (Thr-Lys-Pro-Arg), plus C-terminal Pro-Gly-Pro [6]
CAS number80714-61-0 [12]129954-34-3
Molecular formula (free base)C37H51N9O10S [12]C33H57N11O9
Average molecular weight813.9 g/mol [12]751.9 g/mol
Monoisotopic mass (calculated)813.348 Da751.434 Da
[M+H]+ (calculated)814.355752.441
[M+2H]2+ (calculated)407.681376.724
Oxidation-sensitive residueMet1None (no Met, Cys or Trp)
Russian registrationNasal drops [7]Nasal drops [8]
US statusNot FDA-approved [9–11]Not FDA-approved

Development history

Semax was designed in the Soviet Union and later Russia as a stabilized analogue of the adrenocorticotropin fragment ACTH(4-10). Its sequence keeps the first four residues of that fragment (Met-Glu-His-Phe, corresponding to ACTH 4-7) and replaces the remainder with the tripeptide Pro-Gly-Pro [4]. In a 1997 Russian-language review, Ashmarin and colleagues described roughly 15 years of design and investigation of the peptide [1]. The literature calls Semax an “ACTH(4-10) analogue” [2][3], although its residues come only from ACTH(4-7).

Selank was designed and produced at the Institute of Molecular Genetics of the Russian Academy of Sciences, in cooperation with the V.V. Zakusov Research Institute of Pharmacology [6]. It is a synthetic analogue of tuftsin, the Thr-Lys-Pro-Arg fragment of the human immunoglobulin G heavy chain. The authors state that the C-terminal Pro-Gly-Pro was added to increase metabolic stability [6]. Both peptides share this Pro-Gly-Pro extension, and much of the work on both comes from overlapping Moscow research groups [2][5][6].

Regulatory status

Russia

Both peptides appear in the Russian RLS drug reference as registered medicinal products, listed as nasal drops and manufactured by the Moscow company Peptogen [7][8]. Russian registration is not evidence of efficacy or safety under US regulatory standards.

United States

Neither Semax nor Selank is an FDA-approved drug. Semax free base and Semax acetate were on the agenda of FDA’s Pharmacy Compounding Advisory Committee in July 2026 [9]. In its briefing document, FDA proposed that neither form be included on the 503A Bulks List [10]. The committee then voted in favor of inclusion, as reported by RAPS [11]. Committee votes are advisory, and FDA makes the final decision [11]. Selank was not on that meeting agenda [9].

Published research areas

Most of the literature is preclinical and comes from Russian research groups, and some appears only in Russian-language journals [1][5]. Human data are limited, and the studies summarized below should be read as reported findings, not established effects.

Semax: binding and BDNF studies in rats

Dolotov and colleagues reported specific, reversible, calcium-dependent binding of tritium-labeled Semax to rat basal forebrain membranes, and reported that BDNF protein levels rose in the rat basal forebrain but not in the cerebellum after Semax administration [2]. In a second 2006 paper, the same group studied BDNF and its receptor trkB in the rat hippocampus [3].

Semax: gene expression in an experimental ischemia model

Medvedeva and colleagues ran a genome-wide transcriptional analysis of rat frontoparietal cortex after permanent middle cerebral artery occlusion [4]. Compared with ischemic controls, Semax-treated animals showed altered expression of genes related to the immune response and the vascular system, with immunoglobulin and chemokine genes mainly upregulated at 24 hours. The data were deposited in ArrayExpress (E-MTAB-1864) [4].

Selank and Semax: enkephalin-degrading enzymes

Kost and colleagues reported that both heptapeptides inhibited enkephalin-degrading enzymes in human serum in vitro, in a dose-dependent manner, with reported IC50 values of about 10 μM for Semax and 20 μM for Selank [5]. Pentapeptide fragments retained inhibitory activity, while shorter fragments did not [5].

Selank: GABAergic gene expression

Volkova and colleagues used real-time PCR arrays to measure 84 neurotransmission-related genes in the frontal cortex of male Wistar rats after Selank or GABA administration [6]. They reported 45 genes with altered expression at 1 hour and 22 at 3 hours, and described allosteric modulation of the GABAergic system as a possible mechanism that needs further research [6].

Analytical notes for the laboratory

  • Methionine oxidation (Semax). The N-terminal Met can oxidize to methionine sulfoxide, which adds +15.995 Da ([M+H]+ about 830.350). Check for this peak during MS identity testing, and treat a growing early-eluting reversed-phase peak as a possible oxidation product.
  • No Met in Selank. Selank contains no Met, Cys or Trp, so oxidation is less of a concern. Its Lys and Arg residues make it strongly basic, and it often shows a prominent [M+2H]2+ ion at m/z 376.72.
  • Pro-Gly-Pro motif. Proline-rich sequences can show cis/trans conformers, which may cause broadened or split peaks in reversed-phase HPLC. Confirm by MS before assuming an impurity.
  • Identity values. The calculated monoisotopic [M+H]+ is 814.355 for Semax and 752.441 for Selank (free base). Compare observed values with the Certificate of Analysis.
  • Salt forms. Peptides are often supplied as acetate salts, and FDA’s review treated Semax free base and Semax acetate as separate bulk substances [9]. Counter-ion and water content affect net peptide content.
  • Modified variants are different compounds. “N-acetyl Semax amidate” (N-terminal acetyl, C-terminal amide) has a different formula and mass (calculated [M+H]+ about 855.382) and is not interchangeable with Semax.
  • HPLC. Reversed-phase C18 with a water/acetonitrile gradient and an ion-pairing acid (TFA or formic acid) is the usual approach for purity assessment of short peptides like these.

Kalibra products and resources

Kalibra supplies lyophilized Semax (5, 10 and 30 mg), Selank (5 and 10 mg), and a Selank + Semax blend for laboratory research use only. To check identity and purity data, see how to read a peptide Certificate of Analysis. For storage and handling, see storing and handling lyophilized peptides.

Frequently asked questions

What are Semax and Selank?

They are synthetic heptapeptides developed by Russian research groups. Semax (MEHFPGP) is derived from ACTH(4-10), and Selank (TKPRPGP) is derived from tuftsin. Both carry a C-terminal Pro-Gly-Pro extension [4][6].

Are Semax and Selank approved in the US?

No. Neither is an FDA-approved drug. FDA’s compounding advisory committee reviewed Semax in July 2026; FDA had proposed excluding it from the 503A Bulks List, and the committee’s vote is advisory, with FDA making the final decision [9–11]. Both peptides are registered as nasal drug products in Russia [7][8].

How do the two peptides differ structurally?

Semax contains an N-terminal methionine and is acidic to neutral. Selank contains lysine and arginine and is strongly basic. They share only the Pro-Gly-Pro C-terminus. Their free-base molecular weights are about 813.9 and 751.9 g/mol.

Is N-acetyl Semax amidate the same as Semax?

No. N-terminal acetylation and C-terminal amidation give it a different formula and mass, so it is a distinct compound. Data published for Semax should not be assumed to apply to it.

References

  1. Ashmarin IP, et al. Nootropic analog of adrenocorticotropin 4-10, Semax (15 years of experience in its design and study). Zh Vyssh Nerv Deiat Im I P Pavlova. 1997;47(2):420-430. Russian. PMID 9173745
  2. Dolotov OV, Karpenko EA, Seredenina TS, et al. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem. 2006;97(Suppl 1):82-86. doi:10.1111/j.1471-4159.2006.03658.x
  3. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60. PMID 16996037
  4. Medvedeva EV, Dmitrieva VG, Povarova OV, et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics. 2014;15:228. doi:10.1186/1471-2164-15-228
  5. Kost NV, Sokolov OYu, Gabaeva MV, et al. Semax and Selank inhibit the enkephalin-degrading enzymes of human serum. Russ J Bioorg Chem. 2001;27(3):156-159. doi:10.1023/A:1011373002885
  6. Volkova A, Shadrina M, Kolomin T, et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol. 2016;7:31. doi:10.3389/fphar.2016.00031
  7. RLS Encyclopedia of Drugs (Russia). Semax (Семакс), nasal drops; Peptogen. rlsnet.ru. Russian.
  8. RLS Encyclopedia of Drugs (Russia). Selank (Селанк), nasal drops; Peptogen. rlsnet.ru. Russian.
  9. US Food and Drug Administration. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. fda.gov
  10. US Food and Drug Administration. FDA Briefing Document, Pharmacy Compounding Advisory Committee Meeting (July 24, 2026 session, including Semax). fda.gov/media/193342/download
  11. Eglovitch JS. FDA advisory committee backs two more peptides, rejects one for compounding list. RAPS. July 24, 2026. raps.org
  12. Cayman Chemical. Semax, Item No. 27719: product information. caymanchem.com/product/27719

For Research Use Only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. This guide summarizes published literature for laboratory reference and is not medical advice.

0
Your Cart
Empty CartYour cart is emptyReturn to Shop
Scroll to Top